University of Washington Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Biomarkers in Post-Menopausal Women Receiving Flaxseed
Condition: Healthy, no Evidence of DiseaseInterventions: Dietary Supplement: flaxseed; Other: clinical observation; Other: laboratory biomarker analysisSponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; State University of New York at Buffalo; University of TorontoRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2012 Category: Research Source Type: clinical trials

Internet and Social-Media Program for Improving Quality of Life in Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
Conditions: Cancer Survivor; Depression; Hematopoietic/Lymphoid CancerInterventions: Other: questionnaire administration; Other: survey administration; Procedure: quality-of-life assessment; Other: internet-based intervention; Other: internet-based interventionSponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)Recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2012 Category: Research Source Type: clinical trials

Internet and Social-Media Program for Improving Quality of Life in Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
Conditions: Cancer Survivor; Depression; Hematopoietic/Lymphoid CancerInterventions: Other: questionnaire administration; Other: survey administration; Procedure: quality-of-life assessment; Other: internet-based intervention; Other: internet-based interventionSponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)Recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2012 Category: Research Source Type: clinical trials

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Childh...
Source: ClinicalTrials.gov - January 31, 2012 Category: Research Source Type: clinical trials

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Chronic Phase Chronic Myelogenous Leukemia; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid LeukemiaInterventions: B...
Source: ClinicalTrials.gov - November 29, 2011 Category: Research Source Type: clinical trials